can semaglutide hurt your kidneys Long-term kidney outcomes of in obesity and cardiovascular disease in the SELECT trial Ozempic and GLP-1 Drugs: Risk

rather, its a tool that can effectively support their long-term health goals when used alongside lifestyle interventions

Legal experts expect this number to continue rising as more patients come forward with gastroparesis and related injuries

Key issues in the Ozempic lawsuits include allegations that Novo Nordisk and Eli Lilly, the manufacturers of the drug, did not adequately warn patients about the risk of severe gastroparesis (stomach paralysis) and other adverse effects

1 Year : Weight loss may plateau at this time

doi: 10.1038/jcbfm.2015.32 [DOI] [PMC free article] [PubMed] [Google Scholar] 83.Bowen Lin NK, Hasegawa Y, Sueta D, et al